Bonum Therapeutics, Inc.
Biotechnology company · Seattle, Washington, United States
Bonum Therapeutics, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $27 million sold in a notice filed in 2026.
Bonum Therapeutics at a glance
What does Bonum Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $26.9 million sold (2026).
Frequently asked questions about Bonum Therapeutics
Where is Bonum Therapeutics headquartered?
Bonum Therapeutics, Inc. is headquartered in Seattle, Washington, United States.
What does Bonum Therapeutics do?
Bonum Therapeutics, Inc. is a biotechnology company.
When was Bonum Therapeutics founded?
The earliest incorporation on record for Bonum Therapeutics, Inc. is in 2021, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences